Influence of apolipoprotein E genotype variation on the means, variances, and correlations of plasma lipids and apolipoproteins in children

Annals of Human Genetics

Volumn 63, Issue 4, 1999, Pages 311-328

  Nelson, M R ^a   Kardia, S L R ^b   Ferrell, R E ^c   Sing, C F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; VARIANCE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; APOLIPOPROTEINS; APOLIPOPROTEINS E; BIOMETRY; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARENTS; SEX CHARACTERISTICS; VARIATION (GENETICS);

EID: 0033376358     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0003480099007587     Document Type: Article

References (60)

1. AKERBLOM, H. K., UHARI, M., PESONEX, E., DAHL, M., KAPRIO, E. A., NUUTINEN, E. M., PIETIKAINEN, M., et al. (1991). Cardiovascular risk in 3'oung Finns. Ann. Med. 23, 35-39.
2. AMERICAN HEART ASSOCIATION (1998). 1998 Heart and stroke statistical update. Technical report, American Heart Association.
3. AUSTIN, M. A. (1992). Joint lipid risk factors and coronary heart disease. Circulation 85, 305-307.
4. BADIMON, J. J., FUSTER, V., CHESEBRO, J. H. & BADIMON, L. (1993). Coronary atherosclerosis : a multifactorial disease. Circulation 87(Suppl), II3-II16.
5. BAILEY, J. E. (1999). Lessons from metabolic engineering for functional genomic and drug discovery. Nature Biotechnology 17, 010-018.
6. BARHAM, D. & TRINDER, P. (1972). An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 97, 142-145.
7. BARR, S. I., KOTTKE, B. A. & MAO, S. J. (1981). Improved method for determination of triglycérides in plasma lipoproteins by an enzymatic kit method. Clin. Chem.27, 1142-1144.
8. BARKETT-COXXER, E. (1997). Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95, 252-204.
9. BAR-YAM, Y. (1997). Dynamics of complex systems. Reading, MA: Addison-Wesley.
10. BERENSON, G. S., McMAHAX, C. A., VOORS, A. W., WEBBER, L. S., SRINIVASAX, S. R., FRANK, G. C., FOSTER, T. A., et al. (1980). Cardiovascular risk factors
11. in children -the early natural history of atherosclerosis and essential hypertension. New York: Oxford University Press.
12. BRADSHAW, A. D. (1965). Evolutionary significance of phenotypic plasticity in plants. Adv. Genet. 13, 115-155.
13. CARMENA, R., ROEDERER, G., MAILLOUX, H., LUSSIERCACAN, S. & DAVIGNON, J. (1993). The response to lovostatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism 42, 895-901.
14. COBB, M. 31., TEITLEBAUM, H., Risen, N., JEKEL, J. & OSTFELD, A. (1992). Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation 86, 849-857.
15. DAVIGNON, J. (1993). Apolipoprotein E polymorphism and atherosclerosis. In New horizons in coronary heart disease (eds. G. V. R. Born, C. J. Schwartz), 5.1-5.21. London: Gurr. Sei.
16. DAVIGNON, J., GREGG, R. E. & SING, C. F. (1988). Apolipoprotein E polymorphism and atherosclerosis. Arterioscler. 8, 1-21.
17. EFRON, B. & TIBSHIRANI, R. J. (1993). An introduction to the bootstrap, pp. 88-90. New York: Chapman and Hall.
18. FERRANNINI, E. (1991). Metabolic abnormalities of hypertension. Hypertension 18, 636-639.
19. FISHER, R. A. (1918). The correlation between relatives on the supposition of Mendelian inheritance. Trans. Royal. Soc. Edinburgh 52, 399-433.
20. GARROD, A. E. (1908). Inborn errors of metabolism. Lancet 2, 1-7.
21. LiARoSA, J., OCKENE, I. S., PEARSON, T. A., REED, J., WASHINGTON, R. & SMITH, S. C. JR. (1998). Primary prevention of coronary heart disease : Guidance from Framingham. A statement for healthcare professionals from the AHA Task Force on Risk Reduction. Circulation 97, 1876-1887.
22. HALLMAN, D. 31., BOERWINKLE, E., SAHA, N., SANDHOLZER, C., 3IENZEL, H. J., CSâZâR, A. & UTERMANN, G. (1991). The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49, 338-349.
23. HIXSON, J. E. (1991). Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler. Thromb. 11, 1237-1244.
24. Izzo, C., GRILLO, F. & MURADOR, E. (1981). Improved method for determination of high-density-lipoprotein cholesterol. I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. Clin. Chem. 27, 371-374.
25. JARVIK, G. P., GOODE, E. L., AUSTIN, 31. A., AUWERX, J., DEEB, S., SCHELLENBERG, G. D. & REED, T. (1997). Evidence that the apolipoprotein E-genotype eifects on lipid levels can change with age in males: a longitudinal analysis. Am. J. Hum. Genet. 61, 171-181.
26. KAMBOII, 31.1., FERRELL, R. E. & KOTTKE, B. (1988). Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen the apolipoprotein E polymorphism. J. Lipid. Res. 29, 1535-1543.
27. KAPRIO, J., FERKELL, R. E., KOTTKE, B. A., KAMBOH, M. I. & SING, C. F. (1991). Effects of polymorphisms in apolipoprotein E, A-IV, and H on quantitative traits related to risk of cardiovascular disease. Arterioscler. Thromb. 11, 1330-1348.
28. KAPRIO, J., FERRELL, R. E., KOTTKE, B. A. & SING, C. F. (1989). Smoking and reverse cholesterol transport: evidence for gene-environment interaction. Clin. Genet. 36, 266-208.
29. KOTTKE, B. A., MOLL, P. P., MICHELS, V. V. & WEIDMAX, W. H. (1991). Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin. Prof,. 66, 1198-1208.
30. LAUER, R. M., CONNOR, W. E., LEAVERTON, P.E. & REITER, M. A. & CLARKE, W. R. (1975). Coronary heart disease risk factors in school children: the Muscatine Study. J. Pediatr. 86, 697-706.
31. LEWOXTIN, R. C. (1992). Genotype and phenotype. In Keywords in evolutionary biology (eds. E. Keller & E. A. Lloyd), pp. 137-144. Cambridge, MA: Harvard University Press.
32. MAHLEY, R. W. (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
33. MAILLY, F., MOLL, P. P., KOTTKE, B. A., KAMBOH, M. I., HUMPHRIES, S. E. & FERRELL, R. E. (1992). Estimation of the frequency of isoform-genotype discrepancies at the apolipoprotein E locus in hétérozygotes for the isoforms. Genet. Epidemiol. 9, 239-248.
34. MäNTTäRI, M., KOSKINEN, P., EHNHOLM, C., HUTTUXEX, J. K. & MAXNINEX, V. (1991). Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention.Metabolism 40,217-221.
35. McGiLL, H. C., McMAiiAx, C. A., MALCOM, G. T., OALMAXX, M. C. & STRONG, J. P. (1997). Effects of atherosclerosis in young men and women. Arlerioscler. Thromb. Vase. Biol. 17, 95-106.
36. MOLL, P.P., MICHELS, V. V., WEIDMAX, W. H. & KOTTKE, B. A. (1989). Genetic determination of plasma apolipoprotein AI in a population-based sample. Am. J. Hum. Genet. 44, 124-139.
37. NESTRUCK, A. C., BOUTHILLIER, D., SIXG, C. F. & DAVIGXOX, J. (1987). Apolipoprotein E polymorphism and plasma cholesterol response to probueol. Metabolism 36, 743-747.
38. NETER, J., WASSERMAX, W. & KUTXER, M. H. (1990). Applied linear statistical models: regression, analysis of variance, and experimental designs. 3rd éd., pp. 17-19. Chicago: Irwin Book Team.
39. PDAY (1990). Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Athersclerosis in Youth (PDAY) Research Group. JAJIA. 264, 3018-3024.
40. PORKKA, K. V., TAIMELA, S., KOXTULA, K., LEHTIMAKI, T., AALTO-SETALA, K., AKERBLOM, H. K. & VIIKARI, J. S. (1994). Variability gene effects of DNA polymorphisms at the apo B, apo AI/CIII and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Stud}-. Clin. Genet. 45, 113-121.
41. RAO, D. C., ELSTON, R. C., KULLER, L. H., FEIXLEIB, M., CARTER, C. & HAVLIK, R. (EDS) (1984). Genetic epidemiology of coronary heart disease. Progress in clinical and biological research, Vol. 147. New York: Alan R. Liss.
42. REILLY, S. L., FERRELL, R. E., KOTTKE, B. A., KAMBOH, M. I. & SING, C. F. (1991). The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am. J. Hum. Genet. 49, 1155-11C6.
43. REILLY, S. L., FERRELL, R. E., KOTTKE, B. A. & SING, C. F. (1992). The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. II. Regression relationships with concomitants. Am. J. Hum. Genet. 51, 1311-1324.
44. REILLY, S. L., FERRELL, R. E. & SING, C. F. (1994). The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III. Correlations and covariances. Am. J. Hum. Genet. 55, 1001-1018.
45. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
46. SATTERTHWAITE, F. W. (1946). An approximate distribution of estimates of variance components. Biometrics Bull. 2, 110-114.
47. SCHLICHTING, C. D. & PiGLiucci, M. (1998). Phenotypic evolution: a reaction norm perspective. Sunderland, MA: Sinauer.
48. SHAPIRO, S.S. & WILK, M. B. (1965). An analysis of variance test for normality (complete samples). Biometrika 52, 591-611.
49. SING, C. F. & DAVIGNON, J. (1985). Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37, 268-285.
50. SING, C. F., HAVILAND, M. B. & REILLY, S. L. (1996). Genetic architecture of common multifactorial diseases. In Variation in the Human Genome. Ciba Foundation Symposia 197 (eds. D. Chadwick & G. Cardew), pp. 211-232. Chichester: John Wiley and Sons.
51. SING, C. F. & REILLY, S. L. (1993). Genetics of common diseases that aggregate, but do not segregate in
52. families. In Genetics of cellular, individual, family, and population variability (eds. C. F. Sing & C. L. Hanis). New York : Oxford University Press.
53. SING, C. F. & SKOLNICK, M. (EDS) (1979). Genetic analysis of common diseases. Applications to predictive factors in coronary disease. Progress in clinical and biological research. Vol. 32. New York: Alan R. Liss.
54. SOKAL, R. R. & ROHLF, F. J. (1981). Biometry: the principles and practice of statistics in biological research. 2nd ed., pp. 588-591. New York: WH Freeman.
55. STEXOâRD, J. H., ZERBA, K. E., PEKKANEN, J., EHNHOLM, C., NISSINEN, A. & SING, C. F. (1995). Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91, 2C5-2C9.
56. TAIMELA, S., LEHTIMäKI, T., POEKKA, K. V., RäSäNEN, L. & VIIKAEI, J. S. (1996). The effect of physical activity on serum total and low-density lipoprotein cholesterol concentrations varies with apoliprotein E phenotype in male children and young adults: the Cardiovascular Risk in Young Finns Study.Metabolism 45, 797-803.
57. TURNER, S. T., WEIDMAN, W. H., MICHELS, V. V., REED, T. J., ORMSON, C. L., FULLER, T. & SING, C. F. (1989). Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age. Hypertension 13, 378-391.
58. WEISGRABER, K. H., RALL, S. C. JR. & MAHLEY, R. W. (1981). Human E apoprotein heterogeneity. Cysteinarginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem. 256, 9077-9083.
59. WRIGHT, S. (1923). The roles of mutation, inbreeding, crossbreeding, and selection in evolution. Proc 6th Int. Congr. Genet. 1, 350-366.
60. XHIGNESSE, M., LUSSIER-UACAN, S., SING, C. F., KESSLING, A. M. & DAVTGNON, J. (1991). Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscl. Thromb. 11, 1100-1110.